Danimer Scientific, Inc. (NYSE:DNMR) Sees Significant Decline in Short Interest

Danimer Scientific, Inc. (NYSE:DNMR) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 450,400 shares, a decrease of 97.8% from the October 31st total of 20,350,000 shares. Based on an average daily volume of 38,200 shares, the short-interest ratio is currently 11.8 days. Approximately 16.6% of the company’s stock are sold short.

Analyst Ratings Changes

A number of equities research analysts have recently commented on DNMR shares. TD Cowen cut their target price on Danimer Scientific from $40.00 to $5.50 and set a “hold” rating on the stock in a research note on Thursday, November 21st. Piper Sandler downgraded Danimer Scientific from a “neutral” rating to an “underweight” rating and lowered their target price for the company from $40.00 to $4.00 in a report on Wednesday, November 20th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. XTX Topco Ltd grew its stake in Danimer Scientific by 18.5% during the 3rd quarter. XTX Topco Ltd now owns 86,252 shares of the company’s stock valued at $39,000 after purchasing an additional 13,473 shares during the last quarter. Capital Investment Advisors LLC raised its holdings in Danimer Scientific by 4.9% in the 3rd quarter. Capital Investment Advisors LLC now owns 630,329 shares of the company’s stock worth $286,000 after purchasing an additional 29,200 shares during the period. First Heartland Consultants Inc. raised its holdings in Danimer Scientific by 58.1% in the 3rd quarter. First Heartland Consultants Inc. now owns 81,674 shares of the company’s stock worth $37,000 after purchasing an additional 30,000 shares during the period. Privium Fund Management B.V. raised its holdings in Danimer Scientific by 67.6% in the 2nd quarter. Privium Fund Management B.V. now owns 75,398 shares of the company’s stock worth $42,000 after purchasing an additional 30,398 shares during the period. Finally, Vanguard Group Inc. raised its holdings in shares of Danimer Scientific by 1.0% during the first quarter. Vanguard Group Inc. now owns 5,070,069 shares of the company’s stock valued at $5,526,000 after acquiring an additional 49,913 shares during the last quarter. 33.84% of the stock is currently owned by hedge funds and other institutional investors.

Danimer Scientific Stock Up 30.7 %

NYSE DNMR traded up $1.41 on Wednesday, reaching $6.00. 84,947 shares of the stock traded hands, compared to its average volume of 27,834. The company has a market cap of $18.02 million, a price-to-earnings ratio of -0.18 and a beta of 1.63. The company has a debt-to-equity ratio of 1.80, a quick ratio of 2.05 and a current ratio of 3.28. Danimer Scientific has a 12 month low of $4.42 and a 12 month high of $73.60. The company has a fifty day moving average price of $13.57 and a 200-day moving average price of $18.82.

Danimer Scientific Company Profile

Danimer Scientific, Inc, a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.